A Riboswitch-Driven Era of New Antibacterials

Area of Science:

• Bacterial molecular biology
• RNA structure and function
• Antimicrobial drug discovery

Background:

• Riboswitches are non-coding RNA elements in bacterial 5' UTRs controlling gene expression.
• Ligand binding induces conformational changes in riboswitches, regulating transcription or translation.
• Their crucial role in bacterial metabolism and survival makes them attractive targets for new antibiotics.

Purpose of the Study:

• To review compounds targeting bacterial riboswitches.
• To discuss the role of mainstream antibiotics in modulating riboswitch activity.
• To highlight riboswitches as targets for novel antibacterial agents.

Main Methods:

• Literature review of riboswitch-targeting compounds.
• Analysis of studies on antibiotic modulation of riboswitches.
• Summary of riboswitch structures and functions in pathogens.

Main Results:

• Several riboswitch structures from bacterial pathogens have been elucidated.
• Compounds targeting riboswitches show potential for reduced resistance development.
• Mainstream antibiotics can modulate riboswitch behavior in vitro and in vivo.

Conclusions:

• Riboswitches are promising RNA targets for developing next-generation antibacterials.
• The interplay between mainstream antibiotics and riboswitches warrants further investigation.
• Targeting bacterial regulatory RNAs represents a new frontier in antimicrobial therapy.